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Abstract 
Chromatographic separation of a crude extract obtained from the fungus Aspergillus 
sp., isolated from the Mediterranean sponge Tethya aurantium, yielded a new 
tryptophan derived alkaloid, 3-((1-hydroxy-3-(2-methylbut-3-en-2-yl)-2-oxoindolin- 
3-yl)methyl)-1-methyl-3,4-dihydrobenzo[e][1,4]diazepine-2,5-dione (1) and a new 
meroterpenoid, austalide R (2), together with three known compounds (3-5). The 
structures of the new compounds were unambiguously elucidated on the basis of 
extensive one and two-dimensional NMR (1H, 13C, COSY, HMBC, and ROESY) and 
mass spectral analysis. Interestingly, the compounds exhibited antibacterial activity 
when tested against a panel of marine bacteria, with 1 selectively inhibiting Vibrio 
species and 2 showing a broad spectrum of activity. In contrast, no significant activity 
was observed against terrestrial bacterial strains and the murine cancer cell line 
L5178Y. 
 
Keywords Aspergillus; Marine natural products; Sponge-derived fungi; Tethya 
aurantium. 
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Introduction  
Prevention or treatment of bacterial disease outbreaks in aquacultures is a major 
challenge facing this industry.1 For instance, destructive infections caused by bacteria 
of the genus Vibrio and those causing necrotizing hepatopancreatitis (NHP) are the 
main diseases commonly affecting shrimp farms.2 Hence, there is a great need for new 
antibiotics to combat such diseases and the resulting stock loss, especially with the 
development of bacterial resistance to traditionally used antibiotics.1  
A potential source of novel antibacterial compounds are marine-derived fungi, which 
have attracted considerable attention in recent years.3-5 They have been isolated from 
virtually every possible marine habitat, including inorganic matter, microbial 
communities, plants, invertebrates and vertebrates. In particular, sponges have yielded 
numerous fungal strains, which have been reported to produce a variety of 
pharmacologically active and structurally diverse metabolites.3,6-11 The need of these 
organisms to adapt and survive in an environment that is significantly different from 
that of terrestrial organisms may have shaped their natural product patterns resulting 
in many cases in the production of unique secondary metabolites.12-15  
The chemical profiles of both terrestrial and marine Aspergillus species have been 
studied by several research groups, and a vast diversity of secondary metabolites with 
novel structures and interesting biological activities was already elucidated.16-25 In 
continuation of our previous studies on the sponge-derived Aspergillus sp. strain, 
isolated from the Adriatic Sea sponge Tethya aurantium,6,25 two new compounds, 
3-((1-hydroxy-3-(2-methylbut-3-en-2-yl)-2-oxoindolin-3-yl)methyl)-1-methyl-3,4- 
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dihydrobenzo[e][1,4]diazepine-2,5-dione (1) and austalide R (2), as well as the known 
compounds 8-O-4-dehydrodiferulic acid (3), cytochalasin Z17 (4) and 
dihydroisoflavipucine (5) (Figure 1), were now isolated and identified. All compounds 
exhibited antibacterial activity against marine-derived strains, with 1 selectively 
inhibiting Vibrio species and 2 showing a broad spectrum of activity, which may raise 
the prospect of using such compounds as antifouling agents or to combat epizootics in 
aquaculture in the future. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Structures of 1-7. 
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Results and Discussion 
The crude ethyl acetate extract of the fungus Aspergillus sp. was subjected to repeated 
column chromatography, followed by semi preparative HPLC separation, to afford 
two new compounds (1 and 2), along with three known compounds (3-5) (Figure 1).  
The molecular formula of 1 was established as C24H25N3O4 on the basis of the 
[M+H]+ signal at m/z 420.1917 in the HRESIMS. The UV absorbance bands observed 
at λmax (MeOH) 214.1, 250.1 and 290.0 nm suggested the presence of an indoline 
chromophore.26 The 1H NMR and COSY spectra of 1 (Table 1) revealed the presence 
of eight aromatic protons corresponding to two ABCD spin systems resonating at δH 
7.30, 6.90, 7.21, 6.73 ppm (H-5 to H-8, respectively) and at δH 7.24, 7.50, 7.18, 7.27 
ppm (H-18 to H-21, respectively), an olefinic ABX spin system at δH 4.94/5.02 (H2-24) 
and 6.07 (H-23) ppm, an aliphatic ABX spin system at δH 2.30/2.70 (H2-10) and 2.90 
(H-11) ppm, two geminal methyl groups at δH 0.98 ppm (H3-25 and H3-26), a nitrogen 
bearing methyl group at δH 3.15 ppm (H3-27), and a NH group at δH 8.18 ppm (H-17).  
The 13C NMR (Table 1) and DEPT spectra confirmed the presence of 24 carbon 
atoms in the structure of 1, including one aliphatic and nine olefinic methine groups, 
one aliphatic and one olefinic methylene groups, three methyl groups, as well as two 
aliphatic and seven olefinic quaternary carbon atoms, the latter including three amide 
carbonyl carbons resonating at δC 172.3, 169.9, and 166.8 ppm (C-2, C-12, and C-16, 
respectively). Furthermore, analysis of the HMQC spectrum allowed the assignment 
of proton signals to the corresponding proton bearing carbon atoms. 
Table 1. 1H, 13C NMR, COSY and HMBC data of 1 at 300 (1H) and 100 (13C) MHz 
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(DMSO-d6, δ in ppm, J in Hz) 
Position δH  δC  COSY HMBC 
1     
2  172.3   
3  54.7   
4  124.8   
5 7.30 d (7.8) 126.6 6 3, 7, 9 
6 6.90 dt (0.1, 7.6) 120.8 5, 7 4, 7, 8 
7 7.21 t (7.7) 128.0 6, 8 5, 8, 9 
8 6.73 d (7.6) 106.3 7 4, 6, 9 
9  142.7   
10 2.30 dd (7.7, 14.9) 
2.70 dd (3.2, 14.9) 
28.9 11 2, 3, 4, 11, 12, 22 
11 2.90 brm 49.6 10, 17  
12  169.9   
13     
14  140.1   
15  128.2   
16  166.8   
17 8.18 d (5.9)  11 10, 11, 15 
18 7.24 d (8.3) 121.6 19 15, 20 
19 7.50 dt (1.7, 8.5) 132.0 18, 20 14, 18, 21 
20 7.18 t (8.4) 125.1 19, 21 15, 18 
21 7.27 d (8.3) 128.8 20 14, 16, 19 
22  41.8   
23 6.07 dd (10.8, 17.4) 142.9 24 22, 25, 26 
24 4.94 dd (0.1, 17.4) 
5.02 dd (0.1, 10.9) 
113.4 23 22, 23 
25 0.98 s 21.3  3, 22, 23, 26 
26 0.98 s 22.5  3, 22, 23, 25 
27 3.15 s 34.9  12, 14 
 
 
The identified spin systems of 1 were connected based on inspection of the HMBC 
spectrum (Table 1, Figure 2). Correlations of the tertiary methyl group protons H3-27 
(δC 34.9 ppm) to the amide carbonyl C-12 and to C-14 (δC 140.1 ppm), of H-18 to 
C-15 (δC 128.2 ppm) and C-20, of H-21 to C-14, C-16 and C-19, of the amide proton 
H-17 to C-10 (δC 28.9 ppm), C-11 (δC 49.6 ppm) and C-15, and of H2-10 to C-11 and 
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C-12, established the 1-methyl-1,4-benzodiazepine-2,5-dione moiety of 1. Further 
correlations of H2-10 to C-2 (δC 172.3 ppm), C-3 (δC 54.7 ppm), C-4 (δC 124.8 ppm), 
and C-22 (δC 41.8 ppm), of H-5 to C-3, C-7 and C-9 (δC 142.7 ppm), and of H-8 to 
C-4, C-6 and C-9, corroborated the presence of an indolin-2-one moiety and revealed 
its connection with the 1,4-diazepine-2,5-dione ring through CH2-10. The 
2-methylbut-3-en-2-yl side chain was verified by correlations of both methyl groups 
CH3-25 (δC 21.3 ppm ) and CH3-26 (δC 22.5 ppm) to each other and to C-3, C-22, and 
C-23 (δC 142.9 ppm), of the olefinic proton H-23 to C-22, C-25 and C-26, and of 
H2-24 (δC 113.4 ppm) to C-22 and C-23. The hydroxyl group was located at N-1 as the 
assignment of all other atoms was completed, and based on comparison of observed 
chemical shift values with those reported for similar 1-hydroxyindolin-2-one 
substructures.27 Hence, 1 was determined as a novel metabolite with an unusual 
structural framework and named 3-((1-hydroxy-3-(2-methylbut-3-en-2-yl)- 
2-oxoindolin-3-yl)methyl)-1-methyl-3,4-dihydrobenzo[e][1,4]diazepine-2,5-dione. 
Attempts to determine the relative configuration of 1 by analysis of the ROESY 
spectrum failed due to free rotation around the methylene bridge CH2-10. 
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Figure 2. Key COSY ( ) and HMBC (    ) correlations observed for 1. 
 
HRESIMS indicated the molecular formula C25H32O9 for 2 in accordance with the 
[M+H]+ signal at m/z 477.2119. Its UV spectrum showed characteristic maxima of an 
austalide at λmax (MeOH) 222.6 and 268.5 nm.28 The 1H and 13C NMR spectra (Table 
2) revealed five methyl groups at δH (δC) 0.79 (18.2), 1.29 (28.8), 1.32 (29.1), 1.43 
(25.6) and 1.99 (10.5) ppm (CH3-27, -24, -26, -25 and -23, respectively), and one 
methoxy group at δH 4.01 (δC 62.5) ppm (OCH3-29). Additionally, four methylene 
groups were observed, including the oxygenated benzylic methylene group at C-1 (δH 
5.25, δC 68.1 ppm), and three methine groups, two of which situated on 
oxygen-bearing carbon atoms based on their chemical shift values at δH (δC) 3.89 
(67.6) and 4.83 (59.5) ppm (CH-13 and CH-22, respectively).  
Table 2. 1H, 13C NMR, COSY, HMBC and ROESY data of 2 (δ in ppm, J in Hz) 
NH
N
O
O
N
OH
OH
27
14
15
17
11
12
10
9
4
1
2
24
25
2622
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Position δHa  δCb COSY
a
 HMBCa ROESYc  
1 5.25 s 68.1  3,4,7,8,9  
3 
 168.6    
4 
 107.0    
5 
 156.7    
6 
 119.4    
7 
 157.2    
8 
 113.9    
9 
 147.3    
11 
 75.2    
12 2.01 d (4.7) 
2.20 d (14.3) 
42.8 13 11, 14  
13 3.89 brs 67.6 12  26 
13-OH 4.62 brs     
14 
 85.5    
15 
 83.8    
17 
 117.1    
17-OH 7.04 brs     
18 1.50 m, 1.74 m 30.6 19 17,20  
19 1.80 m, 1.93 m 31.0 18 17  
20 
 38.0    
21 2.34 brs 46.3 22 6,11,19,20,22,24,27 24 
22 4.83 d (2.8) 59.5 21 6,7,11,20 27 
22-OH 5.20 brs   6  
23 1.99 s 10.5  6,7,8,9  
24 1.29 s 28.8  11,12,21 21 
25 1.43 s 25.6  14,15,26 27 
26 1.32 s 29.1  14,15,25  
27 0.79 s 18.2  14,19,20,21 22,25 
29 4.01 s 62.5  5  
a
 300 MHz (DMSO-d6) 
b
 75 MHz (DMSO-d6) 
c
 600 MHz (MeOH-d4)  
 
Furthermore, three hydroxyl groups were observed at δH 4.62, 5.20 and 7.04 ppm (13-, 
22-, and 17-OH, respectively). The 13C NMR (Table 2) and DEPT spectra confirmed 
the presence of 25 carbon atoms in the structure, including 12 quaternary carbon 
atoms. These data were in accordance with the data reported for austalide O,6 
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previously isolated from the same fungal strain, suggesting that 2 has the same 
molecular skeleton as austalide O. Comparison of the NMR spectra of both 
compounds disclosed the disappearance of the methoxy group located at C-17 of 
austalide O in 2 and the appearance of a hydroxyl group (δH 7.04 ppm) instead. This 
was also consistent with the 14 amu decrease in the molecular weight of 2 compared 
to austalide O.6 The structure of 2 was further confirmed by inspection of COSY, 
HMQC and HMBC spectra (Table 2). Based on the ROESY spectrum of 2, 
comparison of the optical rotation values and the corresponding chirality centers of 
austalides M and O,6 2 was assigned to have (11S,13R,14R,20R,21S,22S) absolute 
configuration. Accordingly, 2 was characterized as a new natural product named 
austalide R. 
The known compounds (3-5) were identified as 8-O-4-dehydrodiferulic acid,29,30 
cytochalasin Z1731 and dihydroisoflavipucine,32 respectively, by comparing their data 
(1H and 13C NMR, MS and [α]D) with literature values. This is the first report of 4 and 
5 from a sponge-derived fungus. Previous studies described the isolation of 4 from A. 
terreus and A. flavipes obtained from Artemisia annua and the mangrove plant 
Acanthus ilicifolius,31,33 respectively, and of 5 from Phoma sp. isolated from Salsola 
oppositifolia.32 
Compounds 1-5, in addition to austalides M (6) and N (7) that were previously 
isolated from the same fungal strain,6 were evaluated for their antibacterial activity 
against a panel of terrestrial and marine-derived bacteria, as well as for their cytotoxic 
activity against the murine cancer cell line L5178Y. All compounds showed 
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antibacterial activity against marine-derived strains (Table 3), at levels sometimes 
equivalent and/or lower than the positive control SeanineTM for Vibrio harveyi, V. 
natriegens, Roseobacter litoralis, Pseudoalteromonas elyakovii, Halomonas 
aquamarina, Polaribacter irgensii and Shewanella putrefaciens. Austalides 2 and 6 
showed a broad spectrum of activity inhibiting 8 out of 11 tested strains at MIC values 
equal or inferior to the SeanineTM’s ones (for V. harveyi, R. litoralis, P. elyakovii, H. 
aquamarina, P. irgensii and S. putrefaciens), whereas 7 inhibited only V. natriegens 
and R. litoralis. This indicates that a bulky substituent at C-22 may alter the spectrum 
of antibacterial activity. Furthermore, 1 exclusively inhibited Vibrio species, 4 
exhibited selective and pronounced activity against R. litoralis (with a significantly 
lower MIC than SeanineTM), and 5 displayed strong activity against S. putrefaciens 
and V. natriegens. In contrast, only 5 showed considerable activity against terrestrial 
Staphylococcus aureus. Furthermore, all compounds proved inactive against the 
murine cancer cell line L5178Y in the cytotoxicity assay. These data indicate that 
compounds 1-7 selectively inhibit marine-derived bacterial strains and lack 
cytotoxicity as judged from the cell line assay. This is of special interest as it may 
raise the prospect of using such compounds as antifouling agents or to combat 
epizootics in aquaculture in the future. 
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Table 3. Results of antibacterial assay for 1-7 expressed as Minimum Inhibitory Concentrations (MIC) 
Bacterial strain 
  
MIC [µg/mL]a 
Seanine 1 2 3 4 5 6 7 
Terrestrial     
Escherichia coli 1 >10 >10 >10 >10 >10 >10 >10 
Staphylococcus aureus 0.0001 >10 >10 >10 >10 0.001 >10 >10 
Marine 
Halomonas aquamarina 0.1 >10 0.1 >10 >10 >10 0.001 >10 
Polaribacter irgensii 1 >10 0.1 >10 >10 >10 0.01 >10 
Pseudoalteromonas elyakovii 0.1 >10 0.1 >10 >10 >10 0.001 >10 
Roseobacter litoralis 1 >10 0.01 1 0.0001 10 0.001 0.01 
Shewanella putrefaciens 1 >10 0.1 >10 >10 0.001 0.001 >10 
Vibrio harveyi 1 1 0.1 >10 >10 >10 0.001 >10 
V. natriegens 1 1 >10 >10 10 0.001 10 0.01 
V. proteolyticus 0.01 0.1 0.1 0.1 >10 >10 >10 >10 
V. carchariae 0.0001 0.1 0.01 1 >10 >10 0.01 >10 
a
 MIC values indicating the same or higher bioactivity than Seanine are highlighted.  
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